Published • loading... • Updated
Pig kidney transplant success leads to new clinical trial at Massachusetts General Hospital
The FDA authorized a 33-patient trial to test safety and effectiveness of gene-edited pig kidneys for end-stage kidney disease patients on dialysis, addressing organ shortages.
- A 54-year-old man is faring well after receiving an experimental pig kidney transplant at Massachusetts General Hospital.
- Tim Andrews, another New Hampshire man, has been off dialysis for a record seven months after receiving a gene-edited pig kidney transplant.
- The FDA has approved a clinical trial of pig kidney xenotransplants for 30 people age 50 or older who are on dialysis.
Insights by Ground AI
58 Articles
58 Articles
Newsbug.info+21 Reposted by 21 other sources
New Hampshire Man Doing Well After Experimental Pig Kidney Transplant
By Nadia Kounang, CNN Scientists are making progress in research into the performance of pig organs in humans, and are now ready for the next step: larger-scale clinical trials. eGenesis, one of the biotech companies developing genetically modified pigs whose organs are transplanted into humans, said Monday that the US Food and Drug Administration has given the green light for human trials involving kidneys from its pigs. “It’s a very optimistic…
·Panama City, United States
Read Full ArticleCoverage Details
Total News Sources58
Leaning Left14Leaning Right3Center36Last UpdatedBias Distribution68% Center
Bias Distribution
- 68% of the sources are Center
68% Center
L 26%
C 68%
Factuality
To view factuality data please Upgrade to Premium
